NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst
Go back to NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 60.29 -0.45 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.74 | 52 Week High | $77.12 | |||
| Open | $60.43 | 52 Week Low | $49.03 | |||
| Day High | $60.43 | P/E | 39.15 | |||
| Day Low | $59.45 | EPS | $1.54 | |||
| Volume | 11,401,701 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 143.93 -1.21 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.14 | 52 Week High | $108.63 | |||
| Open | $143.56 | 52 Week Low | $71.39 | |||
| Day High | $144.65 | P/E | 79.52 | |||
| Day Low | $142.77 | EPS | $1.81 | |||
| Volume | 4,921,303 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 456.69 -4.13 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $460.82 | 52 Week High | $134.71 | |||
| Open | $457.30 | 52 Week Low | $73.31 | |||
| Day High | $460.00 | P/E | N/A | |||
| Day Low | $450.67 | EPS | $-1.98 | |||
| Volume | 1,171,644 | |||||
